Literature DB >> 24890999

Historical implant or current best standard? Minimum five year follow-up outcomes of cemented Thompson hemiarthroplasties.

Al-Amin Kassam1, Shelley Griffiths1, Gordon Higgins1.   

Abstract

UK NICE guidelines recommend abandoning the Thompson hemiarthroplasty (TH) in favour of a 'proven prosthesis' such as the Exeter Trauma Stem. The aim of this study was to assess the hip fracture treatment with the TH. Between 2002 and 2006, 430 cemented THs were performed (minimum 5 year follow-up). Death rates at 1 year and 5 years were 26.6% and 67.4% with low complication (Dislocation 1.4%) and revision rate (1.2%). The TH remains a reliable and proven implant in appropriate patients (over the age of 80, with low activity levels, low ambulatory status and who maybe cognitively impaired), due to low complication and revision rates. Modern implants may provide better function or longevity, but there is little evidence to support abandoning the TH.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NICE; Thompson; femur; fracture; hemiarthroplasty; hip

Mesh:

Substances:

Year:  2014        PMID: 24890999     DOI: 10.1016/j.arth.2014.04.032

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Thompson's hip hemiarthroplasty for neck of femur fracture: remarkable clinical outcomes at 45-year follow-up.

Authors:  Thomas Donnelly; Hosam E Matar; N Greville Farrar
Journal:  BMJ Case Rep       Date:  2017-07-27

2.  Cemented Thompson's hemiarthroplasty in patients with intracapsular neck of femur fractures: survival analysis of 1,670 procedures.

Authors:  S K Khan; S S Jameson; A Sims; J A'Court; M R Reed; A Rangan; S D Muller
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-09-27

3.  The World Hip Trauma Evaluation Study 3: Hemiarthroplasty Evaluation by Multicentre Investigation - WHITE 3: HEMI - An Abridged Protocol.

Authors:  A L Sims; N Parsons; J Achten; X L Griffin; M L Costa; M R Reed
Journal:  Bone Joint Res       Date:  2016-01       Impact factor: 5.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.